CI
NVRO

Cambiar Investors’s NEVRO CORP. NVRO Stock Holding History

Cambiar Investors’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-13,678
Closed -$1.18M – 163
2019
Q3 		$1.18M Sell
13,678
-5,576
-29% -$422K 0.04% 131
2019
Q2 		$1.25M Sell
19,254
-3,321
-15% -$207K 0.03% 134
2019
Q1 		$1.41M Buy
+22,575
New +$1.06M 0.03% 139

Other funds holding NVRO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cambiar Investors's NVRO Position: Q4 2019 in Review

Cambiar Investors sold out of NEVRO CORP. (NVRO) in Q4 2019, closing a stake of 13,678 shares — an estimated $1.18M sold.

Cambiar Investors first reported a position in NVRO in Q1 2019 and held it in 3 quarters. The position peaked at $1.41M in Q1 2019. 191 funds tracked by Wall St. Rank hold NVRO as of Q4 2019.

  • Cambiar Investors reported no remaining NEVRO CORP. position as of Q4 2019 after selling out during the quarter.
  • Cambiar Investors sold 13,678 NEVRO CORP. shares in Q4 2019, an estimated $1.18M.
  • Cambiar Investors first reported a position in NEVRO CORP. in Q1 2019 and held it in 3 quarters.
  • Cambiar Investors's NEVRO CORP. position peaked at $1.41M in Q1 2019.
  • 191 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2019.

Based on Cambiar Investors's 13F filing for Q4 2019, filed 6 Feb 2020.